1. Home
  2. SNY

as of 11-18-2026 11:15am EST

$47.33
$0.22
-0.47%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Founded: 1994 Country:
France
France
Employees: N/A City: N/A
Market Cap: 95.7B IPO Year: 2001
Target Price: $54.92 AVG Volume (30 days): 4.1M
Analyst Decision: Buy Number of Analysts: 11
Dividend Yield:
5.09%
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $39.07 - $50.60 Next Earning Date: 10-30-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 3.68% Revenue Growth (next year): 6.69%
P/E Ratio: 6.14 Index: N/A
Free Cash Flow: N/A FCF Growth: +6.29%

Share on Social Networks: